NL-OMON22667招募中不适用
TwinLife: TWIN Longitudinal Investigation of FEtal discordance
The Dutch Heart Foundation0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •MC twin pregnancies
- •- Parents aged = 18 years, who are able to consent
- •- Written informed consent from both parents to participate in this longitudinal study
排除标准
- •- The presence of major anatomical abnormalities
- •- Triplet pregnancies or higher order multiple pregnancies
- •- Twin reversed arterial perfusion (TRAP)
- •- MC twins with single or double fetal demise
研究者
相似试验
尚未招募
4 期
Study on Effect of Teneligliptin versus Sitagliptin based on ECG changes (Electro Cardiogram for QT interval) in type 2 diabetes mellitus patients.CTRI/2018/10/016150Dr Sujoy Ghosh
进行中(未招募)
1 期
A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chronic hepatitis B. - NEPTUNEChronic hepatitis BMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2006-000870-63-FRF.Hoffmann-La Roche Ltd524
进行中(未招募)
不适用
A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chronic hepatitis B. - NEPTUNEIn adult patients with HBeAg positive chronic hepatitis B.MedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2006-000870-63-DEF. Hoffmann-La Roche Ltd524
已完成
不适用
Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Submuscular Breast Augmentatio-Z411 Other plastic surgery for unacceptable cosmetic appearanceOther plastic surgery for unacceptable cosmetic appearanceZ411PER-010-07PFIZER S.A.,
招募中
不适用
Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the Netherlands * The TWIN studyNL-OMON53107Maag-, Darm- en Leverziekten & Laboratorium voor Translationele Immunologie444
